All Professionals
Overview
Anna Hardcastle is an associate in the Corporate practice and is based in the firm's New York office. Her practice focuses on mergers & acquisitions and emerging growth companies.
Ms. Hardcastle received her law degree from the University of Southern California Gould School of Law in 2021, where she served as Executive Editor of the Interdisciplinary Law Journal. She earned a Bachelor of Arts (magna cum laude) degree in English from the University of Pennsylvania in 2018. Ms. Hardcastle is admitted to practice law in New York.
Representations
- Advised SD Biosensor and SJL Partners on $1.53B Acquisition of Meridian Bioscience
- Advised Orchestra BioMed in Merger with Health Sciences Acquisitions Corporation 2, Strategic Collaboration and Closing of Series D Financing
- Advised Aerojet Rocketdyne’s Independent Director Slate Led by CEO Eileen Drake in Successful Takeover Defense
- Advised RIV Capital in acquisition of New York-Based Etain in Expansion of Cannabis Market
news
- Paul Hastings Advised EnfraGen in the Acquisition of Six Renewable Projects in Central America and Related Financing - November 21st, 2023
- Paul Hastings Advises BLU Logistics in its Sale to the Rhenus Group - September 25th, 2023
- Paul Hastings Advised Galway Sustainable Credit in Significant Investment from Macquarie Asset Management - June 15th, 2023
- Paul Hastings Advised Baker Hughes in NET Power’s $1.5 Billion Business Combination with Rice Acquisition Corp. II - June 9th, 2023
- Paul Hastings Advises Glenfarne Energy in Acquisition of Six Renewable Operating Assets in Panama and Costa Rica - May 12th, 2023
- Paul Hastings Advised Oakley Capital Portfolio Company vLex in Acquisition of Fastcase - April 12th, 2023
- Paul Hastings Advises Luz del Sur in Solar Power Plant Acquisition - April 4th, 2023
- Paul Hastings Advised SD Biosensor and SJL Partners in Acquisition of Meridian Bioscience - February 6th, 2023
- Paul Hastings Advises International Media Investments in JV with Jeff Zucker and RedBird Capital Partners - December 13th, 2022
- Paul Hastings Advises Prize in Business Combination with Rose Hill Acquisition Corporation - October 20th, 2022
- Paul Hastings Advises Primary Wave in a $2 Billion Partnership with Brookfield Asset Management - October 11th, 2022
- Paul Hastings Advises Orchestra BioMed in Merger with Health Sciences Acquisitions Corporation 2, Strategic Collaboration and Closing of Series D Financing - July 5th, 2022
- Paul Hastings Advises Aerojet Rocketdyne’s Independent Director Slate Led by CEO Eileen Drake in Successful Takeover Defense - June 30th, 2022
- RIV Capital to Acquire New York-Based Etain in Expansion of Cannabis Market - March 30th, 2022